Minor histocompatibility antigens as determinants for graft-versus-host disease after allogeneic haematopoietic stem cell transplantation

被引:11
|
作者
Turpeinen, H. [1 ]
Ojala, P. J. [1 ]
Ojala, K. [2 ]
Miettinen, M. [1 ]
Volin, L. [3 ]
Partanen, J. [1 ]
机构
[1] Finnish Red Cross Blood Serv, Helsinki 00310, Finland
[2] Univ Helsinki, FIMM Inst Mol Med Finland, Helsinki, Finland
[3] Univ Helsinki, Cent Hosp, Dept Med, Div Haematol, Helsinki, Finland
关键词
RISK-ASSESSMENT; ACUTE GVHD; DISPARITY; RELEVANCE; MISMATCH; HA-1;
D O I
10.1111/iji.12051
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Minor histocompatibility antigens (minor H antigens) are genetically polymorphic peptides that have been shown to elicit immune response when mismatched between donor and recipient of haematopoietic stem cell transplantation (HSCT). Depending on the expression profiles, mismatches in these genes may either lead to harmful graft-versus-host (GvH) reaction or desired graft-versus-leukaemia (GvL) effect. We analysed retrospectively the effect of HLA-restricted matching 11 established autosomal minor H antigens on the risk of graft-versus-host disease and relapse in 311 HLA-matched sibling HSCT of a single centre. Increased incidence of chronic GvH disease was shown to be associated with mismatches in the HA-8 and ACC-1. The mRNA expression profiles in a large set of healthy and malignant tissue samples of minor H antigen genes demonstrated in silico that the expression profiles of HA-8 and ACC-1 were surprisingly different: HA-8 gene was expressed in practically all tissues, whereas ACC-1 gene had a restricted profile. The results demonstrated that mismatches in minor H antigens HA-8 and ACC-1 predisposed to chronic graft-versus-host disease (GvHD).
引用
收藏
页码:495 / 501
页数:7
相关论文
共 50 条
  • [41] Recipient Immune Modulation with Atorvastatin for Acute Graft-versus-Host Disease Prophylaxis after Allogeneic Transplantation
    Kanate, Abraham S.
    Hari, Parameswaran N.
    Pasquini, Marcelo C.
    Visotcky, Alexis
    Ahn, Kwang W.
    Boyd, Jennifer
    Murthy, Guru Subramanian Guru
    Rizzo, J. Douglas
    Saber, Wael
    Drobyski, William
    Michaelis, Laura
    Atallah, Ehab
    Carlson, Karen S.
    D'Souza, Anita
    Fenske, Timothy S.
    Cumpston, Aaron
    Bunner, Pamela
    Craig, Michael
    Horowitz, Mary M.
    Hamadani, Mehdi
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (08) : 1295 - 1302
  • [42] Acute and chronic Graft-versus-Host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation
    Couriel, DR
    Saliba, RM
    Giralt, S
    Khouri, I
    Andersson, B
    de Lima, M
    Hosing, C
    Anderlini, P
    Donato, M
    Cleary, K
    Gajewski, J
    Neumann, J
    Ippoliti, C
    Rondon, G
    Cohen, A
    Champlin, R
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (03) : 178 - 185
  • [43] Profile of Toll-Like Receptors on Peripheral Blood Cells in Relation to Acute Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation
    Skert, Cristina
    Fogli, Manuela
    Perucca, Simone
    Garrafa, Emirena
    Fiorentini, Simona
    Fili, Carla
    Bergonzi, Cesare
    Malagola, Michele
    Turra, Alessandro
    Colombi, Chiara
    Cattina, Federica
    Alghisi, Elisa
    Caruso, Arnaldo
    Russo, Domenico
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : 227 - 234
  • [44] Vedolizumab in highly resistant acute gastrointestinal graft-versus-host disease after allogeneic stem cell transplantation: A single-center pediatric series
    Rosa, Monika
    Jarmolinski, Tomasz
    Miskiewicz-Migon, Izabella
    Liszka, Karolina
    Miskiewicz-Bujna, Justyna
    Panasiuk, Anna
    Fraczkiewicz, Jowita
    Ussowicz, Marek
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2022, 31 (03): : 345 - 350
  • [45] Cutaneous graft-versus-host disease after hematopoietic stem cell transplant - a review
    Villarreal Villarreal, Cesar Daniel
    Salas Alanis, Julio Cesar
    Jaime Perez, Jose Carlos
    Ocampo Candiani, Jorge
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2016, 91 (03) : 336 - 343
  • [46] Impact of Defibrotide in the Prevention of Acute Graft-Versus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation
    Tilmont, Remi
    Yakoub-Agha, Ibrahim
    Ramdane, Nassima
    Srour, Micha
    Coiteux, Valerie
    Magro, Leonardo
    Odou, Pascal
    Simon, Nicolas
    Beauvais, David
    ANNALS OF PHARMACOTHERAPY, 2022, 56 (09) : 1007 - 1015
  • [47] Recent infection with SARS-CoV-2 in donors was associated with a higher incidence of acute graft-versus-host disease in recipients undergoing allogeneic haematopoietic stem cell transplantation
    Lin, Fan
    Xu, Lanping
    Han, Tingting
    Xu, Zhengli
    Liu, Jing
    He, Yun
    Chen, Yao
    Chen, Huan
    Han, Wei
    Chen, Yuhong
    Fu, Haixia
    Zhang, Yuanyuan
    Mo, Xiaodong
    Wang, Fengrong
    Wang, Jingzhi
    Cheng, Yifei
    Yan, Chenhua
    Sun, Hui
    Wang, Yu
    Zhang, Xiaohui
    Huang, Xiaojun
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (02) : 452 - 462
  • [48] Platelet and Red Blood Cell Transfusions and Risk of Acute Graft-versus-Host Disease after Myeloablative Allogeneic Hematopoietic Cell Transplantation
    Gjaerde, Lars Klingen
    Sorensen, Anne Louise Tolboll
    von Stemann, Jakob Hjorth
    Fischer-Nielsen, Anne
    Hansen, Morten Bagge
    Sengelov, Henrik
    Ostrowski, Sisse Rye
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (10): : 866.e1 - 866.e9
  • [49] Graft conditioning with fluticasone propionate reduces graft-versus-host disease upon allogeneic hematopoietic cell transplantation in mice
    Varady, Erika S.
    Ayala, L. Angel
    Nguyen, Pauline U.
    Scarfone, Vanessa M.
    Karimzadeh, Alborz
    Zhou, Cuiwen
    Chen, Xiyu
    Greilach, Scott A.
    Walsh, Craig M.
    Inlay, Matthew A.
    EMBO MOLECULAR MEDICINE, 2023, 15 (09)
  • [50] Comparison of methotrexate dosing protocols for graft-versus-host disease prophylaxis after unrelated hematopoietic stem cell transplantation
    Nakamura, Naokazu
    Kanda, Junya
    Kondo, Tadakazu
    Kitano, Toshiyuki
    Ikeda, Takashi
    Imada, Kazunori
    Takaya, Ryosuke
    Kubo, Tomoyo
    Mitsuyuki, Satoshi
    Oka, Satoko
    Yonezawa, Akihito
    Takeoka, Tomoharu
    Akasaka, Takashi
    Hishizawa, Masakatsu
    Yago, Kazuhiro
    Tsunemine, Hiroko
    Watanabe, Mitsumasa
    Itoh, Mitsuru
    Takaori-Kondo, Akifumi
    CYTOTHERAPY, 2025, 27 (03) : 307 - 315